Triglycerides and risk of atherosclerotic cardiovascular disease: An update
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triglycerides and risk of atherosclerotic cardiovascular disease: An update
Authors
Keywords
Triglycerides, Triglyceride-rich lipoproteins, Remnants, Cardiovascular risk
Journal
Archives of Cardiovascular Diseases
Volume 114, Issue 2, Pages 132-139
Publisher
Elsevier BV
Online
2021-02-06
DOI
10.1016/j.acvd.2020.11.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study
- (2020) Milad Nazarzadeh et al. EUROPEAN HEART JOURNAL
- Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study
- (2020) Morten Kaltoft et al. EUROPEAN HEART JOURNAL
- The association between triglycerides and incident cardiovascular disease: What is “optimal”?
- (2020) Tsion Aberra et al. Journal of Clinical Lipidology
- Triglycerides and residual risk
- (2020) Antonio J. Vallejo-Vaz et al. Current Opinion in Endocrinology Diabetes and Obesity
- Causes and Consequences of Hypertriglyceridemia
- (2020) Chris J. Packard et al. Frontiers in Endocrinology
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remnant cholesterol and coronary atherosclerotic plaque burden assessed by computed tomography coronary angiography
- (2019) Andrew Lin et al. ATHEROSCLEROSIS
- The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
- (2019) Jean-Charles Fruchart et al. Cardiovascular Diabetology
- Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials
- (2019) Nicholas A. Marston et al. CIRCULATION
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Clinical review on triglycerides
- (2019) Ulrich Laufs et al. EUROPEAN HEART JOURNAL
- Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease
- (2019) Mohamed B Elshazly et al. European Journal of Preventive Cardiology
- APOC3Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular RiskHighlights
- (2018) Anders B. Wulff et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial
- (2018) Antonio J. Vallejo-Vaz et al. CIRCULATION
- Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke
- (2018) Michael V. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease
- (2018) Anum Saeed et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Advances in lipid-lowering therapy through gene-silencing technologies
- (2018) Børge G. Nordestgaard et al. Nature Reviews Cardiology
- Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks
- (2018) Theingi Aung et al. JAMA Cardiology
- Increased Residual Cardiovascular Risk in Patients with Diabetes and High vs. Normal Triglycerides Despite Statin-Controlled LDL Cholesterol
- (2018) Gregory A. Nichols et al. DIABETES OBESITY & METABOLISM
- High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk
- (2018) Peter P. Toth et al. Journal of the American Heart Association
- The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
- (2018) Pratik B Sandesara et al. ENDOCRINE REVIEWS
- Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program
- (2018) Derek Klarin et al. NATURE GENETICS
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Genetically Enhanced Lipoprotein Lipase–Mediated Lipolysis and Low-Density Lipoprotein Cholesterol–Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes
- (2018) Luca A. Lotta et al. JAMA Cardiology
- Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study
- (2017) Christian M Madsen et al. EUROPEAN HEART JOURNAL
- Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease
- (2017) Amit V. Khera et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ANGPTL3 Deficiency and Protection Against Coronary Artery Disease
- (2017) Nathan O. Stitziel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis
- (2016) Kiran Musunuru et al. CIRCULATION RESEARCH
- Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease
- (2016) A.-M. K. Jepsen et al. CLINICAL CHEMISTRY
- The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis
- (2016) Jan Borén et al. CURRENT OPINION IN LIPIDOLOGY
- Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
- (2016) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins
- (2015) Gregory G. Schwartz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Common variants associated with plasma triglycerides and risk for coronary artery disease
- (2013) Ron Do et al. NATURE GENETICS
- Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment
- (2013) Anette Varbo et al. PHARMACOLOGY & THERAPEUTICS
- Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
- (2012) Anders Berg Jørgensen et al. EUROPEAN HEART JOURNAL
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease
- (2009) Ole Faergeman et al. AMERICAN JOURNAL OF CARDIOLOGY
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial
- (2008) Michael Miller et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started